Who is sponsoring NCT04527835?

NCT04527835 is sponsored by Assiut University.

What condition does NCT04527835 study?

NCT04527835 studies Viral Myocarditis.

Is NCT04527835 still recruiting?

NCT04527835 is currently status unknown. Last updated 8 October 2020.

Last reviewed 2020-10-08 · How we verify

NCT04527835

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Presentation, Clinical Course and Patterns of Myocardial Damage Due to Viral Myocarditis

Status unknown Last updated 8 October 2020

What this trial tests

trial testing ELIZA, Extraction of nucleic acid ,Determination of viral genome by using PCR, Quantitative real-time PCR to assess viral load ,Immunohistochemistry analysis of EMB. in Viral Myocarditis in 18 participants. Status unknown.

Timeline

1 October 2020

Primary endpoint
1 March 2021

1 March 2021

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	18
Start date	1 October 2020
Primary completion	1 March 2021
Estimated completion	1 March 2021
Sites	1 location across Egypt

Drugs / interventions tested

ELIZA, Extraction of nucleic acid ,Determination of viral genome by using PCR, Quantitative real-time PCR to assess viral load ,Immunohistochemistry analysis of EMB.

Conditions studied

Viral Myocarditis — all drugs for Viral Myocarditis →

Sponsor

Assiut University

Who can join

Adults 18 to 90, any sex, with Viral Myocarditis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Presentation, Clinical Course and Patterns of Myocardial Damage due to Viral Myocarditis

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Viral Myocarditis

Currently open trials in the same condition.

NCT06742008 — Assessment of the Predictive Value of Anti-beta1AR and Anti-L-CaC Antibodies in the Evolution to Dilated Cardiomyopathy · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04527835 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 8 October 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04527835.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing